NCT00547014
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Healthy Volunteers, +3 more
- Locations
-
- Pfizer Investigational Site Overland Park, Kansas, United States
Clinical trial condition
Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.
NCT00547014
NCT00005778
NCT00001212
NCT00181298
NCT00029926
NCT00042523
NCT00011908
NCT00001676
NCT00082511
NCT00493753